The dilemma in pausing J & J vaccine over risk of blood clots: Will it save lives or cost them?

A CDC advisory panel is grappling with the best way to "do no harm" regarding Johnson & Johnson's COVID-19 vaccine and its risk of blood clots.
Source: Los Angeles Times - Science - Category: Science Authors: Source Type: news
More News: COVID-19 | Science | Vaccines